BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8651907)

  • 1. Effect of O-glycosylated mucin on invasion and metastasis of HM7 human colon cancer cells.
    Yoon WH; Park HD; Lim K; Hwang BD
    Biochem Biophys Res Commun; 1996 May; 222(3):694-9. PubMed ID: 8651907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of benzyl-alpha-GalNAc, an inhibitor of mucin glycosylation, on cancer-associated antigens in human colon cancer cells.
    Huang J; Byrd JC; Yoon WH; Kim YS
    Oncol Res; 1992; 4(11-12):507-15. PubMed ID: 1284381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colon cancer mucin: a new ligand for the beta-galactoside-binding protein galectin-3.
    Bresalier RS; Byrd JC; Wang L; Raz A
    Cancer Res; 1996 Oct; 56(19):4354-7. PubMed ID: 8813123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of quantitative mucin variants from a human colon cancer cell line.
    Kuan SF; Byrd JC; Basbaum CB; Kim YS
    Cancer Res; 1987 Nov; 47(21):5715-24. PubMed ID: 3664476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short chain fatty acids inhibit human (SW1116) colon cancer cell invasion by reducing urokinase plasminogen activator activity and stimulating TIMP-1 and TIMP-2 activities, rather than via MMP modulation.
    Emenaker NJ; Basson MD
    J Surg Res; 1998 Apr; 76(1):41-6. PubMed ID: 9695737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
    Hakomori S
    Cancer Res; 1996 Dec; 56(23):5309-18. PubMed ID: 8968075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant O-glycosylation inhibits stable expression of dysadherin, a carcinoma-associated antigen, and facilitates cell-cell adhesion.
    Tsuiji H; Takasaki S; Sakamoto M; Irimura T; Hirohashi S
    Glycobiology; 2003 Jul; 13(7):521-7. PubMed ID: 12672699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of mucin synthesis by benzyl-alpha-GalNAc in KATO III gastric cancer and Caco-2 colon cancer cells.
    Byrd JC; Dahiya R; Huang J; Kim YS
    Eur J Cancer; 1995; 31A(9):1498-505. PubMed ID: 7577079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the O-glycan elongation limits MUC1 incorporation to cell membrane of human endometrial carcinoma cells.
    Porowska H; Paszkiewicz-Gadek A; Anchim T; Wolczynski S; Gindzienski A
    Int J Mol Med; 2004 Mar; 13(3):459-64. PubMed ID: 14767580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gabexate mesilate inhibits colon cancer growth, invasion, and metastasis by reducing matrix metalloproteinases and angiogenesis.
    Yoon WH; Jung YJ; Kim TD; Li G; Park BJ; Kim JY; Lee YC; Kim JM; Park JI; Park HD; No ZS; Lim K; Hwang BD; Kim YS
    Clin Cancer Res; 2004 Jul; 10(13):4517-26. PubMed ID: 15240544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of sialyl Lewis(a) antigen with the metastatic potential of human colon cancer cells.
    Sato M; Narita T; Kimura N; Zenita K; Hashimoto T; Manabe T; Kannagi R
    Anticancer Res; 1997; 17(5A):3505-11. PubMed ID: 9413195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of mucin in colon-cancer metastasis.
    Schwartz B; Bresalier RS; Kim YS
    Int J Cancer; 1992 Aug; 52(1):60-5. PubMed ID: 1323540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Access to peptide regions of a surface mucin (MUC1) is reduced by sialic acids.
    Ho JJ; Cheng S; Kim YS
    Biochem Biophys Res Commun; 1995 May; 210(3):866-73. PubMed ID: 7539263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor beta1.
    Picon A; Gold LI; Wang J; Cohen A; Friedman E
    Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):497-504. PubMed ID: 9641494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bombesin stimulates invasion and migration of Isreco1 colon carcinoma cells in a Rho-dependent manner.
    Saurin JC; Fallavier M; Sordat B; Gevrey JC; Chayvialle JA; Abello J
    Cancer Res; 2002 Aug; 62(16):4829-35. PubMed ID: 12183443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 4-[3,5-bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) on the liver metastasis of colon 26-L5 carcinoma cells.
    Sakukawa R; Murakami K; Ikeda T; Yamada Y; Saiki I
    Oncol Res; 1998; 10(6):287-93. PubMed ID: 9848099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucins secreted by cell lines derived from colorectal mucinous carcinoma and adenocarcinoma.
    Cho M; Dahiya R; Choi SR; Siddiki B; Yeh MM; Sleisenger MH; Kim YS
    Eur J Cancer; 1997 May; 33(6):931-41. PubMed ID: 9291818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene.
    Takaoka A; Hinoda Y; Satoh S; Adachi Y; Itoh F; Adachi M; Imai K
    Oncogene; 1998 Mar; 16(11):1443-53. PubMed ID: 9525743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P- and E-selectins recognize sialyl 6-sulfo Lewis X, the recently identified L-selectin ligand.
    Ohmori K; Kanda K; Mitsuoka C; Kanamori A; Kurata-Miura K; Sasaki K; Nishi T; Tamatani T; Kannagi R
    Biochem Biophys Res Commun; 2000 Nov; 278(1):90-6. PubMed ID: 11071860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of allicin on invasion and metastasis of colon cancer LoVo cell line in vitro].
    Gao Y; Liu YQ; Cao WK; Chen XF; Wan YY; Heng C; Xu LJ
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1382-6. PubMed ID: 19671326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.